An expert on premium research reports, Market Research Future has added a report titled “Global Apraxia Market 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.
Market Research Future added a new research report on Global Apraxia Market and included Current Trends of Market, Industry Size and Shares also the Top Players Success Milestone. MRFR gives Exclusive analysis of Market with Unique Information.
There are several types of apraxia such as ideomotor apraxia, ideational/conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, apraxia of speech, and others. Buccofacial or orofacial apraxia is the most common type, which causes the inability to carry out facial movements on commands such as whistling, coughing, or others.
However, apraxia is found in people with a migraine, especially, in women. According to Migraine Research Foundation, (2014), migraine was the 3rd most prevalent illness in the world. Nearly 1 in 4 U.S. households includes someone with a migraine. Moreover, 12% of the population including children have migraine problem. 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55, which, in turn, is projected increase the market growth.
The Global Apraxia Market is expected to grow at a CAGR of ~ 6.4 % during the forecast period 2018-2023.
Key Players for Global Apraxia Market
Market Research Future (MRFR) recognizes the following companies as the key players in Apraxia Market: There are plenty of large and small market players which operate in this market all over the globe.
- Medtronic Plc.,
- Codman & Shurtleff, Inc.,
- Raumedic AG,
- Sophysa Ltd.,
- MicroPort Scientific Corporation,
- Orsan Medical Technologies, and
- Spiegelberg GmbH,
- Johnson & Johnson,
- Sophysa Ltd,
- Head Sense Medical,
- InfraScan, Inc.,
- Integra Life Sciences Corporation, and others.
Segments for Global Apraxia Market
The global market has been segmented on the basis of types, diagnosis, treatment, and end user. On the basis of types, the market is segmented into ideomotor apraxia, ideational/conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, gait apraxia, limb-kinetic apraxia, oculomotor apraxia, apraxia of speech. On the basis of the diagnosis, the market is segmented into a test to measure upper limb apraxia, MRI, and others. On the basis of treatment, the market is segmented into speech therapy, occupational therapy, physical therapy, and others. On the basis of the end user, the market is segmented into hospitals & clinics, research centers, and others.
Regional Analysis for Global Apraxia Market
The Americas dominate the global apraxia market owing to the presence of a huge patient population with a neurological disorder such as depression, epilepsy, and migraine, high health care spending, and increasing government support for research & development.
Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating neurological disorders such as epilepsy, depression, and heart attacks may have a positive impact on the growth of the market. The growing public awareness further boosts the adoption of these devices in the European market.
Asia Pacific is the fastest growing market across the globe. Japan holds the major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development may drive the market in China and India over the assessment period.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/apraxia-market-4872